Delcath Systems Inc.

2 trials 2 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

5 Countries active

7 Unique IMPs

N/A Results reported

Phase II

Top IMPs

MELPHALAN 2 BEVACIZUMAB 1 CAPECITABINE 1 ERIBULIN 1 TRIFLURIDINE, TIPIRACIL 1 TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE 1 VINORELBINE TARTRATE 1

All trials

2 total

Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Treatment with Eribulin or Vinorelbine or Capecitabine Versus Eribulin or V… Recruiting

2025-521966-91-00 Phase II 2 countries CAPECITABINE; ERIBULIN; MELPHALAN; VINORELBINE TARTRATE
Randomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus … Recruiting

2024-520356-24-00 Phase II 5 countries BEVACIZUMAB; MELPHALAN; TRIFLURIDINE, TIPIRACIL; TRIFLURIDINE, TIPIRACIL HYDROCH…

Showing 1–2 of 2 trials

← All sponsors A–Z